Literature DB >> 28358442

Variations of Vascular Endothelial Growth Factor and Pigment Epithelial-derived Factor Are Related to Retinopathy of Prematurity in Human Babies.

D Zhu1, C Chen2, W Shi3.   

Abstract

BACKGROUND: To examine the role of variations in vascular endothelial growth factor (VEGF) and pigment epithelial-derived factor (PEDF) levels and VEGF/PEDF ratio in predicting the occurrence of retinopathy of prematurity (ROP) in extremely premature human babies.
METHODS: This is a retrospective hospital based case-control study of 54 preterm neonates born at or before 32 weeks of gestation between 2006 and 2007 at the Neonatal Intensive Care Unit of the First People's Hospital affiliated to Fudan University. Birthweight was less than 1250 g. Eleven diagnosed with ROP were identified as cases. A control group of 43 infants, closely matched for birthweight and gestational age, was selected. The levels of VEGF and PEDF were measured at different time points of postnatal ages. Two-way repeated measure analysis of variance (ANOVA) was performed to examine the time trend.
RESULTS: Vascular endothelial growth factor level in ROP cases showed an increasing trend during the postnatal 35 day age (p < 0.01), while it was persistently decreasing in the control group (p = 0.025). In contrast, PEDF level in the control group was steadily increasing with postnatal day ages, while it remained approximately at the same level in the study group. On the other hand, the PEDF/ VEGF ratio in cases was found to be extremely high at the beginning, then continuously declined during the entire study period, while it remained steady in the control group during the same period.
CONCLUSION: Increased expression of VEGF levels was found to be associated with older postnatal day age in our study. Monitoring of variations in VEGF level and PEDF/VEGF ratio might be helpful in predicting the occurrence of ROP in premature human babies.

Entities:  

Keywords:  Pigment epithelial-derived factor; retinopathy of prematurity; vascular endothelial growth factor ratio

Year:  2015        PMID: 28358442     DOI: 10.7727/wimj.2014.210

Source DB:  PubMed          Journal:  West Indian Med J        ISSN: 0043-3144            Impact factor:   0.171


  4 in total

Review 1.  Retinopathy of prematurity: a review of risk factors and their clinical significance.

Authors:  Sang Jin Kim; Alexander D Port; Ryan Swan; J Peter Campbell; R V Paul Chan; Michael F Chiang
Journal:  Surv Ophthalmol       Date:  2018-04-19       Impact factor: 6.048

2.  EARLY VITAMIN A SUPPLEMENTATION IMPROVES THE OUTCOME OF RETINOPATHY OF PREMATURITY IN EXTREMELY PRETERM INFANTS.

Authors:  Huiqing Sun; Rui Cheng; Zhansheng Wang
Journal:  Retina       Date:  2020-06       Impact factor: 3.975

3.  Correlation between apelin and VEGF levels in retinopathy of prematurity: a matched case-control study.

Authors:  Yimin Zhang; Jing Feng; Shuming Shao; Qing Mu; Jie Liu; Chaomei Zeng; Xiaorui Zhang
Journal:  BMC Ophthalmol       Date:  2022-08-11       Impact factor: 2.086

Review 4.  Role of cytokines and treatment algorithms in retinopathy of prematurity.

Authors:  M Elizabeth Hartnett
Journal:  Curr Opin Ophthalmol       Date:  2017-05       Impact factor: 3.761

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.